MFDS — authorised 20 July 2021
- Marketing authorisation holder: ALBIREO PHARMA INC
- Status: likely_approved
🇰🇷 Bylvay in South Korea
MFDS authorised Bylvay on 20 July 2021
Marketing authorisation
Bylvay in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in South Korea
Frequently asked questions
Is Bylvay approved in South Korea?
Yes. MFDS authorised it on 20 July 2021.
Who is the marketing authorisation holder for Bylvay in South Korea?
ALBIREO PHARMA INC holds the South Korean marketing authorisation.